未登录

P

Peng Zhan

Shandong University

H指数:27

被引数:2,765

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical effectiveness of percutaneous vertebroplasty in elderly patients with osteoporotic lumbar vertebral fractures: A retrospective study (vol 69, 101820, 2025)

CURRENT PROBLEMS IN SURGERY

IF1.9

2025-11-010

PRE

Privileged scaffold repurposed: the evolving role of quinolone derivatives in antiviral therapy

优势骨架的再利用：喹诺酮衍生物在抗病毒治疗中不断演变的作用

Bioorganic & Medicinal Chemistry Letters

IF2.2

2025-10-040

PRE

Advances in click chemistry for drug discovery and development

点击化学在药物发现与发展中的进展

Expert Opinion on Drug Discovery

IF4.9

2025-08-300

PRE

Nucleoside antiviral agents with atypical structures and new targets☆

非典型结构及新靶点的核苷类抗病毒剂☆

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

IF2.2

2025-04-010

PRE

A patent review of hepatitis B virus core protein allosteric modulators (2019-present)

EXPERT OPINION ON THERAPEUTIC PATENTS

IF4.6

2025-02-220

PRE

Discovery of Brain-Penetrative Negative Allosteric Modulators of NMDA Receptors Using FEP-Guided Structure Optimization and Membrane Permeability Prediction

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2025-01-140

PRE

Echinatin inhibits osteoarthritis through the NF-κB signaling pathway

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IF3.1

2025-01-020

PRE

NRG-1 Promotes Axon Regeneration of Dorsal Root Ganglion Neurons in Diabetic Rats via ITGB1/FAK/AKT Pathway

NRG-1通过ITGB1/FAK/AKT通路促进糖尿病大鼠背根神经节神经元轴突再生

INTERNATIONAL JOURNAL OF GENOMICS

IF1.9

2025-01-010

OAAI

Identification of novel diarylpyrimidine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against wild-type and K103N mutant viruses

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-12-011

PRE

Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2024-11-012

PRE

The latest developments in the design and discovery of non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2024-10-131

PRE

Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice

1268年6月2，一种有效的SARS-CoV-2木瓜蛋白酶样蛋白酶抑制剂，在小鼠中具有特殊的抗病毒功效

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-09-012

OAAI

Design and optimization of piperidine-substituted thiophene[3,2-d]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profiles

基于哌啶取代的噻吩 [3，2-d] 嘧啶的HIV-1 NNRTIs的设计和优化，具有改善的耐药性和药代动力学特征

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-07-010

OAAI

Discovery of GluN2A subtype-selective N-methyl-D-aspartate (NMDA) receptor ligands

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-05-012

OAAI

Increased Siglec-9/Siglec-9L interactions on NK cells predict poor HCC prognosis and present a targetable checkpoint for immunotherapy

JOURNAL OF HEPATOLOGY

IF33

2024-05-014

PRE

Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-01-0116

OAAI

Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2023-12-011

PRE

Multifunctional agents against Alzheimer's disease based on oxidative stress: Polysubstituted pyrazine derivatives synthesized by multicomponent reactions

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2023-12-012

PRE

Emerging drug design strategies in anti-influenza drug discovery

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-12-017

OAAI

Advances in drug structure-activity-relationships for the development of selenium-based compounds against HIV

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2023-11-203

PRE